132 related articles for article (PubMed ID: 6386695)
1. Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.
Söderström T; Ohman L; Stein K; Schneerson R; Vann WF; Hanson LA
Infection; 1984; 12(4):309-12. PubMed ID: 6386695
[TBL] [Abstract][Full Text] [Related]
2. Studies on immunity against Escherichia coli K13 with monoclonal anti-K13 and anti-anti-K13.
Söderström T; Ohman L; Stein K; Schneerson R; Vann WF; Hanson LA
Infection; 1985; 13 Suppl 2():S256-9. PubMed ID: 3902658
[TBL] [Abstract][Full Text] [Related]
3. Serological, chemical, and structural analyses of the Escherichia coli cross-reactive capsular polysaccharides K13, K20, and K23.
Vann WF; Soderstrom T; Egan W; Tsui FP; Schneerson R; Orskov I; Orskov F
Infect Immun; 1983 Feb; 39(2):623-9. PubMed ID: 6187684
[TBL] [Abstract][Full Text] [Related]
4. Neonatal administration of idiotype or antiidiotype primes for protection against Escherichia coli K13 infection in mice.
Stein KE; Söderström T
J Exp Med; 1984 Oct; 160(4):1001-11. PubMed ID: 6384416
[TBL] [Abstract][Full Text] [Related]
5. The effect of monoclonal antibodies against Escherichia coli type 1 pili and capsular polysaccharides on the interaction between bacteria and human granulocytes.
Söderström T; Ohman L
Scand J Immunol; 1984 Oct; 20(4):299-305. PubMed ID: 6150547
[TBL] [Abstract][Full Text] [Related]
6. Functional activities of monoclonal antibodies to the O side chain of Escherichia coli lipopolysaccharides in vitro and in vivo.
Kim KS; Kang JH; Cross AS; Kaufman B; Zollinger W; Sadoff J
J Infect Dis; 1988 Jan; 157(1):47-53. PubMed ID: 2447199
[TBL] [Abstract][Full Text] [Related]
7. Protective efficacy and immunogenicity of Escherichia coli K13 diphtheria toxoid conjugate against experimental ascending pyelonephritis.
Kumar V; Ganguly Nk; Joshi K; Mittal R; Harjai K; Chhibber S; Sharma S
Med Microbiol Immunol; 2005 Aug; 194(4):211-7. PubMed ID: 15909203
[TBL] [Abstract][Full Text] [Related]
8. Antibodies given orally in the neonatal period can affect the immune response for two generations: evidence for active maternal influence on the newborn's immune system.
Lundin BS; Dahlman-Höglund A; Pettersson I; Dahlgren UI; Hanson LA; Telemo E
Scand J Immunol; 1999 Dec; 50(6):651-6. PubMed ID: 10607314
[TBL] [Abstract][Full Text] [Related]
9. Experimental Escherichia coli ascending pyelonephritis in rats: active peroral immunization with live Escherichia coli.
Mattsby-Baltzer I; Hanson LA; Olling S; Kaijser B
Infect Immun; 1982 Feb; 35(2):647-53. PubMed ID: 7035370
[TBL] [Abstract][Full Text] [Related]
10. Protection against acute, ascending pyelonephritis caused by Escherichia coli in rats, using isolated capsular antigen conjugated to bovine serum albumin.
Kaijser B; Larsson P; Olling S; Schneerson R
Infect Immun; 1983 Jan; 39(1):142-6. PubMed ID: 6337094
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of bacteriophages specific for capsular antigens K3, K7, K12, and K13 of Escherichia coli.
Nimmich W; Krallmann-Wenzel U; Müller B; Schmidt G
Zentralbl Bakteriol; 1992 Jan; 276(2):213-20. PubMed ID: 1559009
[TBL] [Abstract][Full Text] [Related]
12. Structure and serological specificity of the K13-antigenic polysaccharide (K13 antigen) of urinary tract-infective Escherichia coli.
Vann WF; Jann K
Infect Immun; 1979 Jul; 25(1):85-92. PubMed ID: 90016
[TBL] [Abstract][Full Text] [Related]
13. Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS).
Coughlin RT; Bogard WC
J Immunol; 1987 Jul; 139(2):557-61. PubMed ID: 3298431
[TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity of two IgG2a murine monoclonal antibodies with distinct fine specificities for group B Neisseria meningitidis capsular polysaccharide.
Hurpin CM; Carosella ED; Cazenave PA
Hybridoma; 1992 Dec; 11(6):677-87. PubMed ID: 1284118
[TBL] [Abstract][Full Text] [Related]
15. Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.
Kaijser B; Larsson P; Olling S
Infect Immun; 1978 Apr; 20(1):78-81. PubMed ID: 352939
[TBL] [Abstract][Full Text] [Related]
16. N-Propionylated group B meningococcal polysaccharide mimics a unique bactericidal capsular epitope in group B Neisseria meningitidis.
Pon RA; Lussier M; Yang QL; Jennings HJ
J Exp Med; 1997 Jun; 185(11):1929-38. PubMed ID: 9166422
[TBL] [Abstract][Full Text] [Related]
17. Characterisation and protective capacity of monoclonal antibodies elicited in mice against protein epitopes of antibiotic-exposed Escherichia coli.
Lun MT; Raponi G; Amatucci AM; Natali PG; Fraioli R; Mancini C
J Med Microbiol; 1997 Feb; 46(2):122-8. PubMed ID: 9060871
[TBL] [Abstract][Full Text] [Related]
18. Human monoclonal antibody with protective activity for Escherichia coli K1 and Neisseria meningitidis group B infections.
Raff HV; Devereux D; Shuford W; Abbott-Brown D; Maloney G
J Infect Dis; 1988 Jan; 157(1):118-26. PubMed ID: 3121759
[TBL] [Abstract][Full Text] [Related]
19. Protective capacity of antibodies against Escherichia coli and K antigens.
Kaijser B; Ahlstedt S
Infect Immun; 1977 Aug; 17(2):286-9. PubMed ID: 70410
[TBL] [Abstract][Full Text] [Related]
20. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
